SLC6A2 and attention deficit-hyperactivity disorder: A comprehensive meta-analysis involving 12 studies found that certain SLC6A2 variants were significantly associated with treatment response, particularly in hyperactive-impulsive presentations of ADHD, although the effect sizes remained modest (odds ratio ~1.2) [49]. Variants in this gene have been explored in relation to ADHD and treatment response, particularly to MPH.